arginyl-glycyl-aspartic acid has been researched along with Infarct in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Abbasi, MM; Adli, ADF; Behzadi, R; Farajnia, S; Farajzadeh, D; Jahanban-Esfahlan, R; Javaheri, T; Minofar, B; Monhemi, H; Seidi, K; Zare, P; Zarghami, N | 1 |
1 other study(ies) available for arginyl-glycyl-aspartic acid and Infarct
Article | Year |
---|---|
RGD delivery of truncated coagulase to tumor vasculature affords local thrombotic activity to induce infarction of tumors in mice.
Topics: Animals; Bacterial Proteins; Cell Line, Tumor; Cells, Cultured; Coagulase; Humans; Infarction; Mice, Inbred C57BL; Mice, Nude; Mutation; Neoplasms; Neovascularization, Pathologic; Oligopeptides; Recombinant Fusion Proteins; Thrombosis; Tumor Burden; Xenograft Model Antitumor Assays | 2017 |